The Dry Eye Zone

Rebecca's Blog

-

OTC: Tears Again advanced liposome spray

Based on past experience I feel like i need to add a disclaimer to this kind of post:

I am posting this NOT because I am personally recommending the product, but rather because there was a press release and there may be people among my readers (past users of liposome sprays?) who will be interested in knowing. One of my many goals with the websites and newsletter is to help people access products that are not widely known or are not available in every drugstore.

Tears Again® advanced Liposome Spray Now Available at CVS

ROSENBERG, Texas, Aug. 16, 2011 /PRNewswire/ -- OCuSOFT, Inc., an ophthalmic research, development, and supply company is pleased to announce that Tears Again® advanced Liposome Spray, an adjunct to OCuSOFT® Lid Scrub™ Eyelid Cleansers, is now available nationwide at all CVS drug stores.
Recent reports from the International Workshop on Meibomian Gland Dysfunction* (MGD) demonstrate an improvement of symptoms associated with Evaporative Dry Eye and Stage 2 MGD when a liposome spray, namely Tears Again® advanced Liposome Spray, was added to treatment plans. Compared with hyaluronate eye drops and triglyceride gels, the liposome spray was significantly more effective at reducing lid margin inflammation and improving tear film stability.
Utilizing patented liposome technology to deposit water and lipids as well as vitamins A, C, and E, Tears Again® advanced Liposome Spray provides moisture to soothe and relieve discomfort. Simply spray the cool, refreshing mist onto closed eyelids throughout the day as often as needed.
For a complete eyelid hygiene regimen, use Tears Again® advanced Liposome Spray in conjunction with OCuSOFT® Lid Scrub™ Eyelid Cleansers, which are also conveniently available at your local CVS.
For more information, visit www.tearsagainspray.com or call (800) 233-5469.
*Nichols KK, Foulks GN, Bron AJ, Glasgow BJ, Dogru M, Tsubota K, Lemp MA, Sullivan DA. The International Workshop on Meibomian Gland Dysfunction, Investigative Ophthalmology & Visual Science, Special Issue 2011, Vol. 52, No. 4
RebeccaComment